Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Stares MD"'
Autor:
Shao Y; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK. ys4@sanger.ac.uk., Garcia-Mauriño C; Institute for Global Health, University College London, London, UK., Clare S; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Dawson NJR; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Mu A; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Adoum A; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Harcourt K; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Liu J; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Browne HP; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Stares MD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Rodger A; Institute for Global Health, University College London, London, UK., Brocklehurst P; Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK., Field N; Institute for Global Health, University College London, London, UK., Lawley TD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK. tl2@sanger.ac.uk.
Publikováno v:
Nature microbiology [Nat Microbiol] 2024 Oct; Vol. 9 (10), pp. 2570-2582. Date of Electronic Publication: 2024 Sep 06.
Autor:
Crobach MJT; Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: m.j.t.crobach@lumc.nl., Hornung BVH; Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands., Verduin C; Department of Medical Microbiology, Amphia Hospital Breda, the Netherlands., Vos MC; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, the Netherlands., Hopman J; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands., Kumar N; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, United Kingdom., Harmanus C; Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands., Sanders I; Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands., Terveer EM; Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands., Stares MD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, United Kingdom., Lawley TD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, United Kingdom., Kuijper EJ; Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands; Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2023 Jul; Vol. 29 (7), pp. 891-896. Date of Electronic Publication: 2023 Mar 05.
Autor:
Vervier K; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK kv4@sanger.ac.uk., Moss S; Department of Gastroenterology, Addenbrookes Hospital, Cambridge, UK.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Cambridge, Cambridgeshire, UK., Kumar N; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK., Adoum A; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK., Barne M; Department of Dietetics, Addenbrookes Hospital, Cambridge, UK., Browne H; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK., Kaser A; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Cambridge, Cambridgeshire, UK.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, Cambridgeshire, UK., Kiely CJ; Department of Gastroenterology, Royal North Shore Hospital, St Leonards, New South Wales, Australia., Neville BA; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK., Powell N; Department of Dietetics, Addenbrookes Hospital, Cambridge, UK., Raine T; Department of Gastroenterology, Addenbrookes Hospital, Cambridge, UK.; Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK., Stares MD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK., Zhu A; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK., De La Revilla Negro J; Department of Gastroenterology, Addenbrookes Hospital, Cambridge, UK., Lawley TD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, Cambridgeshire, UK., Parkes M; Department of Gastroenterology, Addenbrookes Hospital, Cambridge, UK.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Cambridge, Cambridgeshire, UK.
Publikováno v:
Gut [Gut] 2022 Sep; Vol. 71 (9), pp. 1821-1830. Date of Electronic Publication: 2021 Nov 22.
Autor:
Forster SC; Experimental Cancer Genetics Lab, Wellcome Sanger Institute, Hinxton, UK.; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia., Clare S; Experimental Cancer Genetics Lab, Wellcome Sanger Institute, Hinxton, UK., Beresford-Jones BS; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK., Harcourt K; Experimental Cancer Genetics Lab, Wellcome Sanger Institute, Hinxton, UK., Notley G; Experimental Cancer Genetics Lab, Wellcome Sanger Institute, Hinxton, UK., Stares MD; Experimental Cancer Genetics Lab, Wellcome Sanger Institute, Hinxton, UK., Kumar N; Experimental Cancer Genetics Lab, Wellcome Sanger Institute, Hinxton, UK., Soderholm AT; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK., Adoum A; Experimental Cancer Genetics Lab, Wellcome Sanger Institute, Hinxton, UK., Wong H; Animal Health Trust, Newmarket, UK., Morón B; Experimental Medicine Division, University of Oxford, Oxford, UK., Brandt C; Experimental Cancer Genetics Lab, Wellcome Sanger Institute, Hinxton, UK., Dougan G; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK., Adams DJ; Experimental Cancer Genetics Lab, Wellcome Sanger Institute, Hinxton, UK., Maloy KJ; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK., Pedicord VA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK., Lawley TD; Experimental Cancer Genetics Lab, Wellcome Sanger Institute, Hinxton, UK. tl2@sanger.ac.uk.
Publikováno v:
Nature microbiology [Nat Microbiol] 2022 Apr; Vol. 7 (4), pp. 590-599. Date of Electronic Publication: 2022 Apr 01.
Autor:
Forster SC; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, CB10 1SA, UK. sam.forster@hudson.org.au.; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic, 3168, Australia. sam.forster@hudson.org.au.; Department of Molecular and Translational Science, Monash University, Clayton, Vic, 3800, Australia. sam.forster@hudson.org.au., Liu J; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Kumar N; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Gulliver EL; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic, 3168, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Vic, 3800, Australia., Gould JA; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Vic, 3168, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Vic, 3800, Australia., Escobar-Zepeda A; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Mkandawire T; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Pike LJ; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Shao Y; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Stares MD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Browne HP; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Neville BA; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, CB10 1SA, UK., Lawley TD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, CB10 1SA, UK. tl2@sanger.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2022 Mar 17; Vol. 13 (1), pp. 1445. Date of Electronic Publication: 2022 Mar 17.
Autor:
Beresford-Jones BS; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., Forster SC; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Stares MD; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Notley G; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Viciani E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Browne HP; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Boehmler DJ; Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Soderholm AT; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., Kumar N; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Vervier K; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Cross JR; Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Almeida A; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK; European Bioinformatics Institute, EMBL-EBI, Wellcome Genome Campus, Hinxton, UK., Lawley TD; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. Electronic address: tl2@sanger.ac.uk., Pedicord VA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK. Electronic address: vap33@cam.ac.uk.
Publikováno v:
Cell host & microbe [Cell Host Microbe] 2022 Jan 12; Vol. 30 (1), pp. 124-138.e8. Date of Electronic Publication: 2021 Dec 30.
Autor:
James KR; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. kj7@sanger.ac.uk., Gomes T; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Elmentaite R; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Kumar N; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Gulliver EL; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia., King HW; Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, UK., Stares MD; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Bareham BR; Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Ferdinand JR; Molecular Immunity Unit, Department of Medicine, University of Cambridge, MRC Laboratory of Molecular Biology, Cambridge, UK., Petrova VN; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Polański K; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Forster SC; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia.; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia., Jarvis LB; Department of Haematology, Clifford Allbutt Building, Cambridge, UK., Suchanek O; Molecular Immunity Unit, Department of Medicine, University of Cambridge, MRC Laboratory of Molecular Biology, Cambridge, UK., Howlett S; Department of Haematology, Clifford Allbutt Building, Cambridge, UK., James LK; Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, UK., Jones JL; Department of Haematology, Clifford Allbutt Building, Cambridge, UK.; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Meyer KB; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Clatworthy MR; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Molecular Immunity Unit, Department of Medicine, University of Cambridge, MRC Laboratory of Molecular Biology, Cambridge, UK., Saeb-Parsy K; Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Lawley TD; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Teichmann SA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. st9@sanger.ac.uk.; Theory of Condensed Matter, Cavendish Laboratory, Department of Physics, University of Cambridge, Cambridge, UK. st9@sanger.ac.uk.; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, UK. st9@sanger.ac.uk.
Publikováno v:
Nature immunology [Nat Immunol] 2020 Mar; Vol. 21 (3), pp. 343-353. Date of Electronic Publication: 2020 Feb 17.
Autor:
Shao Y; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Forster SC; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK.; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia., Tsaliki E; Institute for Global Health, University College London, London, UK., Vervier K; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Strang A; Institute for Global Health, University College London, London, UK., Simpson N; Institute for Global Health, University College London, London, UK., Kumar N; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Stares MD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Rodger A; Institute for Global Health, University College London, London, UK., Brocklehurst P; Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK., Field N; Institute for Global Health, University College London, London, UK. nigel.field@ucl.ac.uk., Lawley TD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK. tl2@sanger.ac.uk.
Publikováno v:
Nature [Nature] 2019 Oct; Vol. 574 (7776), pp. 117-121. Date of Electronic Publication: 2019 Sep 18.
Autor:
Kumar N; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK. nk6@sanger.ac.uk., Browne HP; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Viciani E; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Forster SC; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK.; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia., Clare S; Wellcome Sanger Institute, Hinxton, UK., Harcourt K; Wellcome Sanger Institute, Hinxton, UK., Stares MD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK., Dougan G; Wellcome Sanger Institute, Hinxton, UK., Fairley DJ; Belfast Health and Social Care Trust, Belfast, Northern, Ireland., Roberts P; University of Liverpool, Liverpool, UK., Pirmohamed M; University of Liverpool, Liverpool, UK., Clokie MRJ; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK., Jensen MBF; Department of Clinical Microbiology, Slagelse Hospital, Slagelse, Denmark., Hargreaves KR; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK., Ip M; Department of Microbiology, Chinese University of Hong Kong, Shatin, Hong Kong., Wieler LH; Institute of Microbiology and Epizootics, Department of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.; Robert Koch Institute, Berlin, Germany., Seyboldt C; Institute of Bacterial Infections and Zoonoses, Federal Research Institute for Animal Health (Friedrich-Loeffler-Institut), Jena, Germany., Norén T; Faculty of Medicine and Health, Örebro University, Örebro, Sweden.; Department of Laboratory Medicine, Örebro University Hospital Örebro, Örebro, Sweden., Riley TV; Department of Microbiology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, Australia.; School of Pathology & Laboratory Medicine, The University of Western Australia, Nedlands, Western Australia, Australia., Kuijper EJ; Section Experimental Bacteriology, Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands., Wren BW; Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, University of London, London, UK., Lawley TD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Hinxton, UK. tl2@sanger.ac.uk.
Publikováno v:
Nature genetics [Nat Genet] 2019 Sep; Vol. 51 (9), pp. 1315-1320. Date of Electronic Publication: 2019 Aug 12.
Autor:
Forster SC; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. sf15@sanger.ac.uk.; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia. sf15@sanger.ac.uk.; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia. sf15@sanger.ac.uk., Kumar N; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Anonye BO; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.; Microbiology and Infection Unit, Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, UK., Almeida A; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK.; Bacterial Genomics and Evolution Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Viciani E; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Stares MD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Dunn M; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Mkandawire TT; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Zhu A; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Shao Y; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Pike LJ; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Louie T; Department of Microbiology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada., Browne HP; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Mitchell AL; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK., Neville BA; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK., Finn RD; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK., Lawley TD; Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. tl2@sanger.ac.uk.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2019 Feb; Vol. 37 (2), pp. 186-192. Date of Electronic Publication: 2019 Feb 04.